TL;DR: The Centers for Medicare & Medicaid Services modified NCD 220, the National Coverage Determination governing Medicare coverage of self-contained pacemaker monitors, effective March 7, 2026. Here's what billing teams need to do.
CMS updated NCD 220 to clarify coverage criteria and documentation expectations for two device types — digital electronic pacemaker monitors and audible/visible signal pacemaker monitors — billed under the Durable Medical Equipment benefit category. No specific HCPCS codes are listed in the policy document itself, which creates a documentation burden your billing team needs to address before claims go out. The real issue here isn't device coverage — CMS has covered these monitors for years — it's the documentation standard for outpatient pacemaker evaluation when a patient is already using a home monitor.
| Field | Detail |
|---|---|
| Payer | Centers for Medicare & Medicaid Services (CMS) |
| Policy | Self-Contained Pacemaker Monitors |
| Policy Code | NCD 220 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | Medium |
| Specialties Affected | Cardiology, Electrophysiology, DME Suppliers, Outpatient Hospital Billing |
| Key Action | Audit your outpatient pacemaker evaluation documentation before March 7, 2026 to confirm medical necessity is separately supported when a patient already has a home monitor |
CMS Self-Contained Pacemaker Monitor Coverage Criteria and Medical Necessity Requirements 2026
CMS covers the rental or purchase of self-contained pacemaker monitors under the Durable Medical Equipment benefit category when a physician prescribes the device for a patient with a cardiac pacemaker. Two device types qualify: the digital electronic pacemaker monitor and the audible/visible signal pacemaker monitor. Both are explicitly recognized as accepted devices for monitoring cardiac pacemakers under this coverage policy.
The digital electronic pacemaker monitor gives the patient a real-time digital readout of pacemaker pulse rate. Professional services aren't triggered until the pulse rate changes by five or more beats per minute above or below the initial rate — at which point the patient contacts their physician. The audible/visible signal device works differently: it produces a signal the patient can hear and see, and professional contact is required only when that signal changes.
What matters from a billing and reimbursement standpoint is the home-use design of these devices. CMS is explicit that the self-contained monitor is intended to reduce the patient's need for regular outpatient visits. That's not just a clinical observation — it's a direct signal that CMS will scrutinize claims for outpatient pacemaker evaluation when a patient already has a home monitor.
The medical necessity standard is the critical piece here. Per NCD 220, if outpatient pacemaker evaluation is used in addition to a home monitor, documentation of medical necessity for that evaluation must be obtained. This is where claims get denied. If your outpatient billing team isn't capturing a documented clinical rationale for why the in-person evaluation was needed beyond what the home device provides, you're exposed.
Prior authorization isn't specifically called out in the policy text, but DME prior auth requirements under Medicare Advantage plans and supplemental coverage can apply depending on the patient's plan. Check the patient's specific plan before assuming straight Medicare rules apply across the board.
CMS Self-Contained Pacemaker Monitor Exclusions and Non-Covered Indications
NCD 220 doesn't designate any device type as experimental or investigational. Both monitor types are covered. The exclusion risk here is procedural, not device-based.
Outpatient pacemaker evaluation without documented medical necessity — when the patient is already using a self-contained home monitor — is where CMS expects to see claim denial exposure. The policy stops short of calling this non-covered categorically, but it does require affirmative documentation. Absence of that documentation is effectively a non-covered claim waiting to happen.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Rental or purchase of digital electronic pacemaker monitor (physician-prescribed, patient has cardiac pacemaker) | Covered | Not specified in policy | Prescription required; billed under DME benefit category |
| Rental or purchase of audible/visible signal pacemaker monitor (physician-prescribed, patient has cardiac pacemaker) | Covered | Not specified in policy | Prescription required; billed under DME benefit category |
| Outpatient pacemaker evaluation in addition to home monitor use | Covered with documentation | Not specified in policy | Medical necessity must be separately documented; CMS will expect supporting rationale in the chart |
| Outpatient pacemaker evaluation without documented medical necessity when home monitor is in use | At risk for denial | Not specified in policy | NCD 220 explicitly requires documentation in this scenario |
CMS Pacemaker Monitor Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Audit outpatient pacemaker evaluation claims for patients with home monitors before March 7, 2026. Pull a report of outpatient pacemaker evaluation claims where the patient also has a DME monitor on file. Review the documentation in each chart for a distinct medical necessity statement explaining why in-person evaluation was clinically required beyond what the home device captures. |
| 2 | Update your documentation templates for outpatient pacemaker evaluation. Your physicians need a field in the note — or a standalone addendum — that explicitly addresses why the outpatient visit was necessary given the patient's home monitoring status. Generic "pacemaker check" documentation won't hold up to a medical necessity review under this policy. |
| 3 | Confirm the ordering physician's prescription is on file for every DME monitor claim. NCD 220 requires a physician prescription as a condition of payment for both device types. If your DME supplier or cardiology practice doesn't have a clean prescription trail, get it before the claim goes out. |
| 4 | Cross-reference NCD 220 with the Transtelephonic Monitoring of Cardiac Pacemakers NCD. CMS explicitly cross-references these two policies. If your practice also bills for transtelephonic monitoring, verify there's no double-billing exposure when a patient uses a self-contained home monitor and also receives transtelephonic monitoring services. |
| 5 | Flag Medicare Advantage patients for plan-specific prior auth requirements. The base Medicare coverage policy under NCD 220 doesn't require prior authorization, but many Medicare Advantage plans layer their own DME prior auth requirements on top. Check each patient's plan before billing the monitor rental or purchase. A denied claim on a $400 DME item that needed a prior auth is a straightforward fix upstream — and a collection headache downstream. |
| 6 | If your outpatient billing mix includes significant pacemaker evaluation volume, loop in your compliance officer before March 7, 2026. The documentation standard CMS is reinforcing here is clear enough, but how it applies to your specific patient population and billing patterns is worth a compliance review. Don't assume your current process is clean without checking. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Self-Contained Pacemaker Monitors Under NCD 220
NCD 220 as published does not list specific CPT or HCPCS codes in the policy document. This is worth flagging directly: the absence of explicit codes in the NCD means your billing team needs to confirm applicable HCPCS codes for DME pacemaker monitors through the Medicare Coverage Database and your DME MAC's local coverage articles.
CMS's cross-reference to the Transtelephonic Monitoring of Cardiac Pacemakers NCD is relevant here — transtelephonic monitoring carries its own code set, and distinguishing those claims from self-contained monitor claims is a clean-claim requirement.
No codes are listed in the policy data for NCD 220. Do not assume codes from related policies apply without confirming with your DME MAC or billing consultant. Using the wrong HCPCS code on a DME claim — even when the device itself is covered — is a straightforward path to a claim denial or a take-back audit.
Work with your DME MAC to confirm the correct HCPCS codes for digital electronic pacemaker monitors and audible/visible signal pacemaker monitors before the March 7, 2026 effective date. Document which codes your MAC confirms, and update your charge capture accordingly.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.